Clinical Trials of Using Subretinal Implants to Treat Retinitis Pigmentosa Set to Begin in United States
March 18, 2011
Retina Implant AG, a developer of subretinal implants for the visually impaired, yesterday announced that they will partner with the Wills Eye Institute in Philadelphia to conduct clinical trials in the United States using Retina Implant’s subretinal implant technology to treat patients in North America suffering from retinitis pigmentosa.
Retina Implant’s subretinal implant technology has been in clinical trials for more than six years in Germany and plans to expand its second human clinical trial into the U.K. this summer. The results of Retina Implant’s first human clinical trial were published in the prestigious peer-reviewed journal Proceedings of the Royal Society B last November. The results showed placement of the implant below the retina, in the macular region, provided optimum visual results allowing patients to recognize foreign objects and to read letters to form words.
Click here to read the full release.
Jump down to form below to submit your own comments